Fig. 1From: Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaOverall survival (OS) (A), cancer-specific survival (CSS) (B), local regional-free survival (LRFS) (C), distant metastasis-free survival (DMFS) (D), and progression-free survival (PFS) (E) of patients with primary mediastinal seminomaBack to article page